TY  - JOUR 
AU  - Reboredo Lopez, Margarita
AU  - Candamio Folgar, Sonia
AU  - López López, Rafael
AU  - Quintero Aldana, Guillermo
AU  - Salgado Fernández, Mercedes
AU  - De La Cámara Gómez, Juan Cruz
PY  - 2013
SN  - 0250-7005
UR  - http://hdl.handle.net/20.500.11940/1498
LA  - eng
TI  - Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
T2  - ANTICANCER RESEARCH
M2  - 717
VL  - 33
ER  -